SHARE
 
Igor I. Slukvin, PhD, MD close
Igor I. Slukvin, PhD, MD

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Igor I. Slukvin, PhD, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Igor I. Slukvin, PhD, MD, earned his medical degree from Kiev Medical University in Ukraine and completed his residency at UW Hospital and Clinics.

Specialties

Pathology

Clinics

University Hospital
(608) 263-8443 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Pathology and Laboratory Medicine

Professional Certifications and Education

Board Certification Anatomic & Clinical Pathology
Residency University of Wisconsin Hospital and Clinics, Madison, WI
Medical School Kiev International Medical University, Kiev, Ukraine

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Manian KV Galloway CA Dalvi S Emanuel AA Mereness JA Black W Winschel L Soto C Li Y Song Y DeMaria W Kumar A Slukvin I Schwartz MP Murphy WL Anand-Apte B Chung M Benoit DSW Singh R 3D iPSC modeling of the retinal pigment epithelium-choriocapillaris complex identifies factors involved in the pathology of macular degeneration. Cell Stem Cell . 2021 Mar 29;
[PubMed ID: 33784497]
Jung HS Uenishi G Park MA Liu P Suknuntha K Raymond M Choi YJ Thomson JA Ong IM Slukvin II SOX17 integrates HOXA and arterial programs in hemogenic endothelium to drive definitive lympho-myeloid hematopoiesis. Cell Rep . 2021 Feb 16;34(7):108758
[PubMed ID: 33596423]
D'Souza SS Bennett S Kumar A Kelnhofer LE Weinfurter J Suknuntha K Coonen J Mejia A Simmons H Golos T Hematti P Capitini CM Reynolds MR Slukvin II Transplantation of T-cell receptor α/β-depleted allogeneic bone marrow in nonhuman primates. Exp Hematol . 2021 Jan;93:44-51
[PubMed ID: 33176119]
Suknuntha K Choi YJ Jung HS Majumder A Shah S Slukvin I Ranheim EA Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition. Front Oncol . 2020;10:585151
[PubMed ID: 33363015]
Strelchenko NS Schmidt JK Mean KD Schotzko ML Golos TG Slukvin II Cryopreservation of Mauritian Cynomolgus Macaque (<i>Macaca fascicularis</i>) Sperm in Chemically Defined Medium. J Am Assoc Lab Anim Sci . 2020 Nov 1;59(6):681-686
[PubMed ID: 32878681]
Bloor AJC Patel A Griffin JE Gilleece MH Radia R Yeung DT Drier D Larson LS Uenishi GI Hei D Kelly K Slukvin I Rasko JEJ Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study. Nat Med . 2020 Nov;26(11):1720-1725
[PubMed ID: 32929265]
Schmidt JK Strelchenko N Park MA Kim YH Mean KD Schotzko ML Kang HJ Golos TG Slukvin II Genome editing of CCR5 by CRISPR-Cas9 in Mauritian cynomolgus macaque embryos. Sci Rep . 2020 Oct 28;10(1):18457
[PubMed ID: 33116147]
Majumder A Suknuntha K Bennin D Klemm L Brok-Volchanskaya VS Huttenlocher A Slukvin I Generation of Human Neutrophils from Induced Pluripotent Stem Cells in Chemically Defined Conditions Using <i>ETV2</i> Modified mRNA. STAR Protoc . 2020 Sep 18;1(2)
[PubMed ID: 33043305]
Kumar A D'Souza SS Uenishi G Park MA Lee JH Slukvin II Generation of T cells from Human and Nonhuman Primate Pluripotent Stem Cells. Bio Protoc . 2020 Jul 5;10(13):e3675
[PubMed ID: 33659345]
Brok-Volchanskaya VS Bennin DA Suknuntha K Klemm LC Huttenlocher A Slukvin I Effective and Rapid Generation of Functional Neutrophils from Induced Pluripotent Stem Cells Using ETV2-Modified mRNA. Stem Cell Reports . 2019 Dec 10;13(6):1099-1110
[PubMed ID: 31708474]
Ozog S Timberlake ND Hermann K Garijo O Haworth KG Shi G Glinkerman CM Schefter LE D'Souza S Simpson E Sghia-Hughes G Carillo RR Boger DL Kiem HP Slukvin I Ryu BY Sorrentino BP Adair JE Snyder SA Compton AA Torbett BE Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes. Blood . 2019 Oct 17;134(16):1298-1311
[PubMed ID: 31416800]
Mesquitta WT Wandsnider M Kang H Thomson J Moskvin O Suknuntha K Slukvin II UM171 expands distinct types of myeloid and NK progenitors from human pluripotent stem cells. Sci Rep . 2019 Apr 29;9(1):6622
[PubMed ID: 31036928]
Slukvin II Uenishi GI Arterial identity of hemogenic endothelium: a key to unlock definitive hematopoietic commitment in human pluripotent stem cell cultures. Exp Hematol . 2019 Mar;71:3-12
[PubMed ID: 30500414]
Ozay EI Vijayaraghavan J Gonzalez-Perez G Shanthalingam S Sherman HL Garrigan DT Jr Chandiran K Torres JA Osborne BA Tew GN Slukvin II Macdonald RA Kelly K Minter LM Cymerusâ„¢ iPSC-MSCs significantly prolong survival in a pre-clinical, humanized mouse model of Graft-vs-host disease. Stem Cell Res . 2019 Mar;35:101401
[PubMed ID: 30738321]
Kumar A Lee JH Suknuntha K D'Souza SS Thakur AS Slukvin II NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells. J Immunol . 2019 Feb 1;202(3):770-776
[PubMed ID: 30578305]
Park MA Jung HS Slukvin I Genetic Engineering of Human Pluripotent Stem Cells Using PiggyBac Transposon System. Curr Protoc Stem Cell Biol . 2018 Nov;47(1):e63
[PubMed ID: 30281932]
Slukvin II Kumar A The mesenchymoangioblast, mesodermal precursor for mesenchymal and endothelial cells. Cell Mol Life Sci . 2018 Oct;75(19):3507-3520
[PubMed ID: 29992471]
Suknuntha K Tao L Brok-Volchanskaya V D'Souza SS Kumar A Slukvin I Optimization of Synthetic mRNA for Highly Efficient Translation and its Application in the Generation of Endothelial and Hematopoietic Cells from Human and Primate Pluripotent Stem Cells. Stem Cell Rev Rep . 2018 Aug;14(4):525-534
[PubMed ID: 29520567]
Kang H Mesquitta WT Jung HS Moskvin OV Thomson JA Slukvin II GATA2 Is Dispensable for Specification of Hemogenic Endothelium but Promotes Endothelial-to-Hematopoietic Transition. Stem Cell Reports . 2018 Jul 10;11(1):197-211
[PubMed ID: 29861167]
Park MA Kumar A Jung HS Uenishi G Moskvin OV Thomson JA Slukvin II Activation of the Arterial Program Drives Development of Definitive Hemogenic Endothelium with Lymphoid Potential. Cell Rep . 2018 May 22;23(8):2467-2481
[PubMed ID: 29791856]